Dr. Sarraf founded Amydis in 2013 to address the urgent medical and clinical need for an objective, non-invasive diagnostic to detect amyloid-associated diseases, the most well-known of which is Alzheimer’s Disease (AD). She brings a blend of large pharmaceutical operational expertise, venture investment background and entrepreneurship to Amydis. Dr. Sarraf is viewed as a visionary with a deep understanding of “cradle to grave” and the necessary components to achieve success from product concept through to commercialization.